Preclinical and Translational Sciences
Yurong Lai, PhD (he/him/his)
Executive Director
Gilead Sciences, Inc.
Foster City, California
Rodrigo Cristofoletti, Ph.D. (he/him/his)
University of Florida
Orlando, Florida
The presentation will focus on CDER's perspectives on New Approach Methodologies and the impact of the recently passed Food and Drug Omnibus Reform Act (FDORA) in drug safety assessment.